FOR ORAL ADMINISTRATION
Dosage:
5 mg praziquantel and 20 mg pyrantel base (57.5 mg pyrantel embonate) per kg of body weight. This corresponds to 1 tablet per 4 kg of body weight. Kittens weighing less than 1 kg should not be treated with the product, because correct dosing of such cats may not be feasible.
Body weight | Tablets |
1.0 - 2.0 kg | 0.5 |
2.1 - 4.0 kg | 1 |
4.1 - 6.0 kg | 1.5 |
6.1 - 8.0 kg | 2 |
Administration:
The tablets are to be given directly into the mouth but can be administered in a small amount of food, if necessary.
Duration of treatment:
Single treatment. In ascarid infestation, especially in kittens, complete elimination cannot be expected, so a risk of infection for humans can persist. Repeat treatments should therefore be carried out with a suitable roundworm product at 14 day intervals until 2-3 weeks after weaning.
Use during pregnancy and lactation
The safety of the veterinary medicinal product has not been established during pregnancy. The product should not be used during pregnancy but may be used during lactation.
Interactions
Do not use simultaneously with piperazine compounds, because the specific activities of piperazine (neuromuscular paralysis of the parasites) can inhibit the efficacy of pyrantel (spastic paralysis of the parasites).